September 15, 2026-September 16, 2026 Register Now: C-Path’s 2026 Global Impact Conference C-Path's flagship event is set to return to downtown Washington, D.C. this September 15-16 at the...
May 14, 2026 The Critical Path Institute Podcast: Accelerating Drug Development in Friedreich’s Ataxia, with Ron Bartek The newest Critical Path Institute® (C-Path) podcast features Ron Bartek, president and co-founder of the Friedreich’s Ataxia
May 13, 2026 Electroencephalography during acute painful procedures in neonates: a scoping review Although electroencephalography (EEG) is used to assess neonatal pain in research settings, EEG assessments...
April 28, 2026 Critical Path Institute Awards $456,000 Grant to Advance Next-Generation Therapy for Rare Glycolipid Storage Disorders TUCSON, Ariz., April 28, 2026 — Critical Path Institute® (C-Path) today announced a $456,000 grant to James Shayman...
April 28, 2026 Electroencephalography During Acute Painful Procedures in Neonates: a Scoping Review Although electroencephalography (EEG) is used to assess neonatal pain in research settings...
April 22, 2026 AIRNA Joins C-Path’s Alpha-1 Antitrypsin Deficiency Consortium to Advance Innovative AATD Treatments TUCSON, Ariz., April 22, 2026 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 Antitrypsin...
April 16, 2026-April 17, 2026 C-Path Hosts 2026 Clinical Outcome Assessment Program Annual Meeting C-Path's 2026 Clinical Outcome Assessment (COA) Program Annual Meeting is right around the corner! You're invited to....
April 9, 2026 Hope on the Horizon for ADTKD Patients ADTKD is the second most common genetic kidney disease after Polycystic Kidney Disease, affecting an estimated 75,000–100,000 in
April 8, 2026 Webinar Recording Available: Scalable Approaches to Patient-Centered Benefit–Risk: Defining Patient-Focused Drug Development in Precision Medicine As precision medicine advances, approaches to benefit–risk must evolve beyond traditional models designed...
April 8, 2026 C-Path’s Translational Therapeutics Accelerator Awards $501,000 Grant to Advance Novel Treatment for Cryptosporidiosis in Children TUCSON, Ariz., April 8, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator has awarded...
